To kick off the MS Global Healthcare Conference, onSeptember 14, Risinger and Harrison hosted former FDACommissioner Dr. Scott Gottlieb to discuss COVID vaccines, antibodies, and FDA considerations. Dr. Gottlieb is reasonably confident that one or more COVID vaccines will be successful. He believes the Phase 1 and 2 data published thus far has demonstrated relatively robust immunogenicity and also the…
Morgan Stanley Healthcare Conference: Dr. Scott Gottlieb
A financial market resource for the every-day investor and trader.
-
-
Top Of Mind for June’s OP/EX Week
Seth Golden, , Research Reports, 0
Check out some top-of-mind topics and subject matter surrounding the market ahead of this week’s key economic data and...
-
Fundstrat: Flash In Macro Strategy
Seth Golden, , Research Reports, 0
Larger narrative is Fed “disinflation” is a massive course correction. Strong Jan equity returns borrowing from Feb, but dip...
-
Market and Volatility Commentary: Global Quantitative and Derivatives Strategy
Seth Golden, , Research Reports, 0
Narrative vs. Flows, Liquidity-Volatility-Flows Feedback Loop, QE/QT and Liquidity Narrative vs. Flows By Marko Kolanovic, PhD and Bram Kaplan,...
-
Investing 101: Expect Bumps In The Road
Seth Golden, , Research Reports, 0
The first week of a new year, and the markets continue to trend higher. We don’t know how long...
-
History Doesn’t Always Repeat, But It Often Rhymes
Seth Golden, , Research Reports, 0
If there is 1-thing I’ve learned from the markets over my 24 years, it’s that down is going to...
-
Jam-Packed Week: PCE, Payroll & Fed Statement As Earnings Soar
Seth Golden, , Research Reports, 0
Last week’s jam-packed earnings releases failed to excite investors even as most reporting companies beat analysts’ estimates. About half...
-
Weekly State of the Market: Bad Breadth Leads to Indigestion
Seth Golden, , Research Reports, 0
“If you don’t profit from your investment mistakes, someone else will.” -Yale Hirsch Every trade demands a thesis, be...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00